About 14 results found for searched term "URAT1 inhibitor 1" (0.124 seconds)
Cat.No. | Name | Target |
---|---|---|
M42622 | URAT1&XO inhibitor 1 | Xanthine Oxidase |
URAT1&XO inhibitor 1 is a dual inhibitor of both URAT1 (IC50=~10 μM) and Xanthine Oxidase (IC50=1.01 μM). | ||
M49902 | URAT1 inhibitor 1 | URAT1 |
URAT1 inhibitor 1 is a uric acid transporter 1 (URAT1) inhibitor with an IC50 value of 32 nM for inhibition of uric acid transporter 1 (URAT1).It can be used in studies related to hyperuricemia and gout. | ||
M2440 | Benzbromarone | Animal Modeling |
Benzbromarone is a URAT1 inhibitor that inhibits MDCKII cells over-expressing URAT1 with an IC50 of 0.190 μM. | ||
M5703 | Iguratimod | COX |
T614 | ||
Iguratimod(T-614) is a selective inhibitor of cyclo-oxygenase-2 (COX-2), and inhibits the production of interleukin-1 (IL-1), IL-6, IL-8 and tumour necrosis factor. | ||
M5734 | Lesinurad | URAT1 |
RDEA 594, RDEA-594, RDEA594 | ||
Lesinurad is a URAT1 and OAT inhibitor, is determined to be a substrate for the kidney transporters OAT1 and OAT3 with Km values of 0.85 and 2 µM, respectively. | ||
M14289 | Lesinurad sodium | URAT1 |
RDEA-594 sodium | ||
Lesinurad sodium is a URAT1 and OAT inhibitor, is determined to be a substrate for the kidney transporters OAT1 and OAT3 with Km values of 0.85 and 2 µM, respectively. | ||
M27919 | Epaminurad | URAT1 |
UR-1102 | ||
Epaminurad (UR-1102) is an orally active, potent and selective URAT1 (urate transporter 1) inhibitor, with a Ki of 0.057 μM. Epaminurad quite modestly inhibits OAT1 and OAT3 (organic anion transporter). Epaminurad is a uricosuric agent. Epaminurad can be used for gout and hyperuricemia research. | ||
M27979 | (Z)-Tyrphostin A51 | EGFR/HER2 |
(Z)-AG-183 | ||
(Z)-Tyrphostin A51 is the Z configuration of Lanoconazole A51. Tyrphostin A51 is a potent protein tyrosine kinase (PTK) inhibitor. Tyrphostin A51 inhibits the volume-dependent release of [3H]taurine in a dose-dependent manner. Tyrphostin A51 markedly reduces cellular tyrosyl phosphorylation level. Tyrphostin A51 inhibits both basal and EGF-induced human bone cell proliferation. | ||
M42269 | URAT1 inhibitor 6 | URAT1 |
URAT1 inhibitor 6 is a potent URAT1 inhibitor (IC50: 35 nM for hURAT1). | ||
M42270 | URAT1 inhibitor 7 | URAT1 |
URAT1 inhibitor 7 is a potent URAT1 inhibitor, with an IC50 of 12 nM. | ||
M42272 | URAT1&XO inhibitor 2 | Xanthine Oxidase |
URAT1&XO inhibitor 2 is a dual inhibitor of xanthine oxidase and URAT1, with IC50 of 3.3 μM for xanthine oxidase. | ||
M49901 | URAT1 inhibitor 3 | URAT1 |
URAT1 inhibitor 3 is an orally potent and selective URAT1 inhibitor with an IC50 value of 0.8 nM.URAT1 inhibitor 3 has a uric acid lowering effect and can be used in studies related to gout and hyperuricemia. | ||
M49904 | URAT1 inhibitor 8 | URAT1 |
URAT1 inhibitor 8 is a potent URAT1 inhibitor with an IC50 of 0.001 μM.URAT1 inhibitor 8 can be used in gout related studies. | ||
M49905 | KPH2f | URAT1 |
KPH2f is an orally potent dual URAT1/GLUT9 inhibitor, with IC50s of 0.24 μM and 9.37 μM for URAT1 and GLUT9, respectively.KPH2f had little effect on OAT1 and ABCG2 (IC50s of 32.14 and 26.74 μM, respectively). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.